/PXMBF
PXMBF Stock - Paxman AB (publ)
Healthcare|Medical - DevicesOTC
$3.50+0.00%
+$0.00 (+0.00%) • Dec 19
67
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.50
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $3.85
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for PXMBF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$3.46 – $3.54
TARGET (TP)$4.02
STOP LOSS$3.22
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.47
52W High$3.50
52W Low$3.50
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $253.01M | $220.61M | $156.75M | $96.20M | $78.05M |
| Gross Profit | $175.42M | $146.42M | $101.44M | $64.52M | $50.69M |
| Gross Margin | 69.3% | 66.4% | 64.7% | 67.1% | 64.9% |
| Operating Income | $33.51M | $12.62M | $-1,243,000 | $-10,580 | $-11,690,000 |
| Net Income | $40.20M | $8.33M | $-10,324,000 | $-12,776,000 | $-19,186,000 |
| Net Margin | 15.9% | 3.8% | -6.6% | -13.3% | -24.6% |
| EPS | $2.11 | $0.44 | $-0.54 | $-0.73 | $-1.20 |
Company Overview
Paxman AB (publ), together with its subsidiaries, develops and sells Paxman scalp cooling system to minimize hair loss in connection with chemotherapy treatment in Europe, the United States, Mexico, Japan, Oceania, rest of Asia, and South and Central America. It serves various cancer centers and hospitals. The comapny has a research collaboration agreement with National University Hospital, Singapore for the development of portable cooling and compression device. Paxman AB (publ) was founded in 1996 and is based in Karlshamn, Sweden.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
PXMBFBeat Rate
57%
Last 7 quarters
Avg Surprise
+32.2%
EPS vs Estimate
Beats / Misses
4/3
Last 12 quarters
Latest EPS
$0.01
Q4 2025
EPS Surprise History
Q3 23
+92.0%
$0.04vs$0.02
Q4 23
-117.3%
$-0.01vs$0.05
Q2 24
+239.1%
$0.06vs$0.02
Q2 24
+72.8%
$0.05vs$0.03
Q3 24
-57.1%
$0.03vs$0.06
Q4 24
+6.4%
$0.06vs$0.05
Q1 25
No data
Q4 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Nov 14, 2025 | — | $0.01 | — | — |
Q1 2025 | Mar 31, 2025 | — | $-0.03 | — | — |
Q4 2024 | Dec 31, 2024 | $0.05 | $0.06 | +6.4% | ✓ BEAT |
Q3 2024 | Sep 30, 2024 | $0.06 | $0.03 | -57.1% | ✗ MISS |
Q2 2024 | Jun 29, 2024 | $0.03 | $0.05 | +72.8% | ✓ BEAT |
Q2 2024 | May 23, 2024 | $0.02 | $0.06 | +239.1% | ✓ BEAT |
Q4 2023 | Dec 30, 2023 | $0.05 | $-0.01 | -117.3% | ✗ MISS |
Q3 2023 | Sep 30, 2023 | $0.02 | $0.04 | +92.0% | ✓ BEAT |
Q2 2023 | Jun 30, 2023 | $0.03 | $0.02 | -10.3% | ✗ MISS |
Q1 2023 | Mar 31, 2023 | — | $-0.01 | — | — |
Q4 2022 | Dec 31, 2022 | — | $-0.05 | — | — |
Q3 2022 | Sep 30, 2022 | — | $0.02 | — | — |
Q2 2022 | Jun 30, 2022 | — | $0.00 | — | — |
Q1 2022 | Mar 31, 2022 | — | $-0.03 | — | — |
Q1 2022 | Feb 25, 2022 | — | $-0.01 | — | — |
Q4 2021 | Nov 19, 2021 | — | $-0.03 | — | — |
Q3 2021 | Aug 27, 2021 | — | $-0.04 | — | — |
Q2 2021 | May 26, 2021 | — | $-0.02 | — | — |
Q1 2021 | Feb 26, 2021 | — | $-0.08 | — | — |
Q3 2020 | Sep 30, 2020 | — | $-0.03 | — | — |
Latest News
Loading news...
Frequently Asked Questions about PXMBF
What is PXMBF's current stock price?
Paxman AB (publ) (PXMBF) is currently trading at $3.50 per share. The stock has moved +0.00% today.
What is the analyst price target for PXMBF?
No analyst price targets are currently available for this stock.
What sector is Paxman AB (publ) in?
Paxman AB (publ) operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the OTC exchange.
What is PXMBF's market cap?
Paxman AB (publ) has a market capitalization of $0.15 billion, making it a small-cap company.
Does PXMBF pay dividends?
No, Paxman AB (publ) does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorBCCOY
BICO Group AB (publ)
$0.60
Mkt Cap: $0.2B
CLLKF
BICO Group AB (publ)
$1.97
Mkt Cap: $0.1B
HOFBF
Hofseth BioCare ASA
$0.17
Mkt Cap: $0.1B
IMPZY
Implanet S.A.
$0.08
Mkt Cap: $0.2B
LDXHF
Lumos Diagnostics Holdings Limited
$0.17
Mkt Cap: $0.1B
ORXOY
Orexo AB (publ)
$2.60
Mkt Cap: $0.1B
RCEL
AVITA Medical, Inc.
$3.46
Mkt Cap: $0.1B
SNZZF
Senzime AB (publ)
$0.45
Mkt Cap: $0.1B
VMTHF
Venus Medtech (Hangzhou) Inc.
$0.27
Mkt Cap: $0.1B
VTIAF
FamiCord AG
$6.38
Mkt Cap: $0.1B
Explore stocks similar to PXMBF for comparison